Ads
related to: Therapy Notestherapynotes.com has been visited by 100K+ users in the past month
Search results
Intra-Cellular Therapies (NASDAQ:ITCI) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 8 hours agoIntra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a note issued to ...
Courteney Cox Recalls Johnny McDaid Breaking Up with Her in Therapy: 'I Was So Shocked'
People Magazine· 2 days agoCourteney Cox is reflecting on what she learned after her longtime partner Johnny McDaid broke up...
Wilderness therapy camp failed to check boy's breathing, state report finds
WCNC Charlotte· 2 days agoStaff at a wilderness therapy camp in western North Carolina failed to check if a boy was breathing...
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes
Investor's Business Daily· 20 minutes ago"ResMed is tracking thousands of patients on GLP-1s and using CPAPs, which has shown positive...
Grief like the ocean - Supporting children after the death of a parent by suicide
Asheville Citizen-Times via Yahoo News· 5 hours ago“So much of the beginnings of my career, the foundations were in training and direct care with...
Gain touts positive Phase I results for Parkinson’s therapy
Clinical Trials Arena via Yahoo Finance· 1 day agoGain Therapeutics’ GT-02287 was found to be safe and tolerable in the Phase I trial of the therapy...
Gene Therapy Trial for Sickle Cell Disease Publishes Final Results
Technology Networks· 14 hours agoIn a landmark study, an international consortium led by researchers at Children’s Hospital of...
Courteney Cox Says Johnny McDaid Broke Up With Her in First Minute of Their Therapy Session
ET Online via AOL· 2 days agoCourteney Cox says she walked into a therapy session and found herself single after just one minute....
As ketamine therapy booms, industry insiders worry about patient safety
Market Watch· 1 day agoThe incident raises broader questions about at-home ketamine therapy, the doctors wrote. Guidelines...
Intra-Cellular Therapies (NASDAQ:ITCI) Given New $96.00 Price Target at Mizuho
ETF DAILY NEWS· 3 days agoThe Goldman Sachs Group upped their target price on shares of Intra-Cellular Therapies from $67.00 to $77.00 and gave the stock a neutral rating in a research note on Wednesday ...
Ads
related to: Therapy Notestherapynotes.com has been visited by 100K+ users in the past month